Antisense oligonucleotide to the translation initiation sequence of human c-mpl reduced the proliferation of human CD34+ bone marrow cells in response t o interleukin-3 (IL-3) alone or to the combination of 11-3 and thrombopoietin (TPO). To investigate the molecular basis for these cytokine interactions, we analyzed the relationship between the receptor subunits for IL-3 and TPO and determined whether both receptors activate identical signal transduction pathways. The function of the receptor subunits was characterized in transiently transfected hepatoma cells and fibroblasts by the activation of gene expression via specific regulatory elements and by the stimulation of DNA-binding activity of STAT proteins. Although c-mpl and IL-3 receptor (IL-3R) reconstituted a qualitatively comparable gene regulatory response, there was no detectable functional interaction between their respective receptor subunits. By compar-
Antisense oligonucleotide to the translation initiation sequence of human c-mpl reduced the proliferation of human CD34+ bone marrow cells in response t o interleukin-3 (IL-3) alone or to the combination of 11-3 and thrombopoietin (TPO). To investigate the molecular basis for these cytokine interactions, we analyzed the relationship between the receptor subunits for IL-3 and TPO and determined whether both receptors activate identical signal transduction pathways. The function of the receptor subunits was characterized in transiently transfected hepatoma cells and fibroblasts by the activation of gene expression via specific regulatory elements and by the stimulation of DNA-binding activity of STAT proteins. Although c-mpl and IL-3 receptor (IL-3R) reconstituted a qualitatively comparable gene regulatory response, there was no detectable functional interaction between their respective receptor subunits. By compar-M EMBERS OF THE hematopoietin receptor gene family are characterized by sequence-similar motifs in their extracellular and, for several of the signal transducing subunits, also in their intracellular domains.' The family can be divided into groups based on the identity of shared signal transducing subunits. The groups consist of receptors that use Based on its sequence, c-mpl has been recognized as a member of the hematopoietin receptor family'-8 before its ligand thrombopoietin (TPO) was identified.'"' c-Mpl displayed an overall sequence similarity that was most closely related to IL-3R/3.6 The signaling capacity of c-mpl was recognized in several chimeric receptor contexts, ie, its viral counterpart, v-mpl, which was constitutively active5.I2 and constructs in which the cytoplasmic domain of c-mpl was recombined with the extracellular domain of the IL-4R8 or G-CSFR.'.I3 Antisense oligonucleotides to c-mpl were found to block its expression and subsequent effects on megakaryocyte progenitor ce1ls.l4
The function of most hematopoietin receptors has been defined by the ability of the receptors to control proliferation of hematopoietic cells. To achieve a proliferative cell response, two structural motifs (box 1 and box 2) in the cytoplasmic domains of the signaling subunits are required? It is likely that these motifs are involved in binding and activation of accessory proteins, in particular the protein tyrosine kinases, JAKl and JAK2, and signal transducing proteins (STATs).I5,I6 Several hematopoietin receptors have also been noted to control the expression of immediate growth response genes and the transcriptional activity of differentiated genes. 13, [17] [18] [19] [20] [21] [22] Blood, Vol 86, No 2 (July 15), 1995: pp 557-571 ing the receptor action in different cell lines, we observed that in human hepatoma cells the signaling of c-mpl was 100-fold less sensitive t o TPO than in rat hepatoma cells. However, IL-3R signaling was comparable between the two cell types, suggesting that c-mpl and IL-3R do not use identical signal transducing mechanisms. The cytoplasmic domains necessary for c-mpl signaling were determined by testing deletion mutants. The membrane-proximal box 1 sequence motif was critical for gene regulation and for STAT protein activation that seemed t o involve the Janus kinase 2 (JAW). Because IL-3R was less dependent on JAK2 than c-mpl, different levels of JAW expression may account, in part, for the quantitative difference in IL-3 and TPO response among various cell lines. 0 7995 by The American Society of Hematology.
We established hepatoma cells as experimental systems to characterize the signaling mechanisms of hematopoietin receptors involved in the stimulation of gene transcription via cytokine-responsive elements of the acute-phase plasma protein genes. 23 These systems proved to be useful not only for dissecting the functiodstructure relationship of receptor forms intrinsic to liver, such as those for IL-6-type cytokines, but also nonhepatic receptors, because ectopically expressed receptors could effectively recruit the signal transducing system of the host ~e l l s . '~,~~.~~ By comparing the specificity of gene regulation, we recently observed that hematopoietin receptors exert several signals that are distinguishable by the activation of specific gene elements. Every tested hematopoietin receptor elicited a "hematopoietin receptor signal" that required minimally the presence of the box 1
The signal derived from box 1 and 2 was detectable by the activation of the "cytokine response element (RE)" of the rat al-acid glycoprotein geneI3 and the signal from box 1, 2, and 3 was defined by the activation of "IL-6 RE' ' present in several rat APP genes, such as P fibrinogen, haptoglobin, and h e m~p e x i n . '~.~~.~~ Before its ligand thrombopoietin was known, the specificity of c-mpl signaling had been identified by incorporating its transmembrane and cytoplasmic domain into the chimeric receptor GCsFR-rn~l.'~ G-CSFR-mpl was responsive to G-CSF in liver cells and displayed the same specificity as the receptors for the IL-6-type cytokines in which the box 3 cytoplasmic motif and carboxy terminal portion had been truncated, ie, (140). '3*25a With the cloning of the thrombopoietin, the gene-regulatory action of the native c-mpl could now be assessed. Given the structural similarity of c-rnpl with the IL-3RP-chain and the known, albeit weak, synergistic activity of L-3 on megakaryocyte progenitors, we hypothesized that c-mpl might form part of a novel IL-3-responsive receptor complex. Using heterologous receptor reconstitution assay systems, we show that c-mpl mediates gene induction in hepatic cells and activation of STAT proteins in fibroblasts with a specificity similar to the IL-3R and that this action is independent of coexpressed L-3R subunits. Moreover, a cell line-specific difference in the cytokine responsiveness of c-mpl, but not the E-3R in transfected human and rat hepatoma cells, suggests that these two receptor types use in part distinct signal transduction mechanisms for mediating the gene-regulatory effects.
G-CSFR(56), G-CSFR-gp130(109), and G-CSFR-LIFR-
MATERIALS AND METHODS

Cells.
Rat hepatoma H-35 cells (clone T-7-18)z6 and human hepatoma HepG2 cellsz7 were cultured as described. Mouse L-fibroblasts were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, COS-l cells in minimal essential medium containing 5% fetal calf serum, and human erythroleukemia (HEL) cells and Mo7e cells (provided by Dr M. Caligiuri, Department of Medicine, RPCI, Buffalo, NY) in RPM1 1640 containing 10% fetal calf serum and IL-3 for the latter cell type. All tissue culture media used in this study contained penicillin, streptomycin, and gentamycin.
Megakaryocyte colony assays. Adult human low-density bone marrow cells were selected for CD34 using the 0-sialoglycoprotease method of Sutherland et aLZ8 The effects of antisense oligonucleotides AS3 (GGCCCAGGAGGGCATCTT) and AS6 (TGCTGT-CAGAGCTGAAGC) to c-mpl on the formation of megakaryocyte colonies (colony-forming unit-megakaryocyte [CFU-MK]) cloned from CD34+ cells were studied using the method of Methia et al. '4 As control, the corresponding sense oligonucleosides (S3 and S6) were used. After treatment with oligonucleotides, the cells were washed with Iscove's modified Dulbecco's medium (IMDM) and cultured in a serum-depleted fibrin-clot culture system as previously de~cribed.'~ CFU-MK colony formation in the assay system was stimulated by the addition of IL-3 in the presence or absence of a source of TPO or aplastic anemia serum or by the addition of IL-3, GM-CSF, and steel factor (SLF). Mouse monoclonal antisera to human glycoprotein IIb (CD4lb) was used to identify CFU-MKderived colonies.
Receptor expression vectors. The expression vector used in this study are listed in Table 1 . Several vectors have been described before. Human c-mpl cDNA was cloned from HEL cell cDNA by the polymerase chain reaction ( E R ) using oligonucleotides based on the published sequence6 and subcloned into the expression vector pME18S (a gift of Drs A. Miyajima and K. Maruyama, DNAX, Palo Alto, CA). pGMR138 was used to express the human GM-CSF receptor a-~ubunit.~' A clone encoding the IL-3Ra-subunit was derived by PCR from TF-l cell cDNA using oligonucleotides based on the published sequence3' and was subcloned into pME18S. An expression construct encoding the IL-3R p-subunit3' was kindly provided by Dr A. Lopez (IMVS, Adelaide, Australia). The chimeric human G-CSFR-murine mpl construct was derived from env-mp1.' Briefly, the cDNA fragment encoding the transmembrane and cytoplasmic domain of murine c-mpl were synthesized by PCR and ligated into the expression vector ~D C -3 0 2~~ containing the cDNA fragment encoding the 598 amino acid extracellular domain of human G-CSFR. From this construct we prepared the internal deletions (AI, A2, A3) and carboxy terminal truncations (A4, S S , and SC) according to BBnit et al." The expression vectors for cDNA to murine JAK2 and the dominant-negative kinase mutant JAK2AVIII in PEF-BOS'~ have been de~cribed.'~ CAT reporter gene constructs. To identify the signaling of transfected and endogenous receptors, the reporter genes constructs listed in Table 1 were used. Plasmid p(8XHRRE)-CAT contains eight tandem copies of the 27-bp HRRE sequence (5"GATCCA-TCC'ITCTGGGAA?TCTGATCA-3') with the APRE core nucleoIn the Bgl I1 site of pCAT promoter (Promega, Madison, WI)." pHX (5XIL-6RE)-CAT contains 5 tandem copies of the 23-bp IL-6RE of the rat hemopexin and p(4XSIE)-CAT contains 4 tandem copies of the high-affinity sis-inducible element SIEm67.'9 Plasmid AGP (4XCytRE)-CAT contains 4 tandem copies of the 62-bp AB region of the distal regulatory element of the rat a,-acid glycoprotein in the enhancerless PSV-CAT.~'
Cytokines. cDNA to full-length TPO was cloned by PCR using cDNA derived from human liver (Clontech, Palo Alto, CA) and oligonucleotides based on the published sequence? The cDNA was inserted into pME18S and transfected into COS-7 cells and day-3-conditioned culture medium was collected. The concentration of TPO was estimated by titration on BAF/c-mpl cells to contain -5 X IO4 U/mL (in which 50 U correspond to 50% maximal stimulation). Conditioned medium from mock-transfected COS-7 cells did not produce any stimulatory effect in the assay systems used (see, eg, were treated with 100 ng/mL cytokines, with the exception of ILIp, which was used at 0.5 ng/mL, and TPO, which was used at 5,000 u/mL.
Cell transfection and analysis. Plasmid DNA was transfected into H-35 cells, L cells, and COS-l cells by the diethylaminoethyl (DEAE) dextran method?' HepG2 cells were treated with calcium phosphate mixture?' Established conditions for optimal reconstitution of receptor function were used.I3 Expression of receptor mRNA in transiently transfected hepatoma cell cultures were verified by Northern blot analysis, as described." However, the low transfection efficiency precluded an immunochemical quantitation of the receptor proteins in these cultures. Receptor protein could be detected by Western blotting in transiently transfected fibroblasts (see Fig 7) . CAT gene regulation was determined in cells transfected with a plasmid mixture containing a total of 10 pg DNA/mL and consisting of 6 pg CAT reporter gene construct, 1 pg receptor expression vector, 1.3 pg PIE-MUP as an internal marker?3 and, where necessary, empty expression vector. After 16 hours of recovery, the transfected cell culture was subdivided into 6-well cluster plates. After 24 hours, the subcultures were treated with serum-free medium containing 1 pmol/L dexamethasone and cytokines for an additional 24 hours. Cell extracts were prepared and the CAT activities were determined by using 10-fold serially diluted extract to ensure measurement in the linear range of the enzyme assay system. The CAT activity were calculated for the entire cell extract preparation and then normalized to the amount of the major urinary proteins derived from the internal marker plasmid pIE-MUP.'3.Z3.25.43 The values were expressed relative to the untreated control cultures (defined as 1.0).
Receptor expression and STAT protein activation were analyzed in L-cells (see Fig 6) . Cells in 15-cm diameter dishes were transfected with 3 mL DNA-DEAE dextran complex containing 20 pg receptor expression vector, 5 pg of p(8XHRRE)-CAT, and 2 pg PIE-MUP. The transfected cultures were divided into subcultures. After 24 hours, two subcultures in 10 cmz wells of a 6-well cluster plate were treated for 24 hours with serum-free medium alone or containing cytokines and then processed to determine specific CAT activity. The remaining cultures were maintained for 16 hours in serum-free medium. Cytokine treatment was performed for 15 minutes in serum-free medium followed by analysis of activated STAT proteins.
Transfection into COS-l cells occurred in 10-cm diameter culture dishes using I mL of DNA-DEAE dextran mixture composed of 10 pg receptor expression vector and 2 pg PIE-MUP. After an overnight recovery, the transfected cell culture was divided into two. Twentyfour hours later, the subcultures were maintained for 16 hours in serum-free medium followed by 15 minutes of treatment with or without cytokines. The cells were processed for analysis of activated STAT proteins and expressed receptor proteins.
Electrophoretic mobility shi@ assay (EMSA). Cell cultures were washed three times with phosphate-buffered saline (PBS) and then the cells were scraped off in PBS containing 1 mmol/L sodium vanadate, 10 mmoVL NaF, IO pg/mL leupeptin, IO pg/mL aprotinin, and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF). In the case of COS-l cells, one quarter of the recovered cells was used for Western blot analysis of receptor. Whole cell extracts were prepared according to the procedure of Sadowski et al.3y The double-stranded SIEm67 oligonucleotide served as indicator for the DNA binding activity of STAT proteins with broadest specificity and highest affin-
The oligonucleotide was end-labeled by kinase reaction. Whole cell extract (5 pL) was preincubated in 20 pL reaction volume with 5 pg poly(d1-dC) for 15 minutes on ice followed by the addition of labeled probe. (20,000 cpm) and binding reaction continued for 15 minutes at room temperature. Ten microliters of the reaction mixture was loaded onto a 4% polyacrylamide gel in 0.5X Tris-borate EDTA buffer. In all EMSA experiments, extracts of untransfected cells that had been treated for 15 minutes with IL-6 were included as standards indicating the relative mobilities of the SIE-bound protein complexes termed SIF-A, -B, and -C?9 Identification of the STAT proteins contributing to the SIE complexes was performed by electrophoretic mobility "supershift assay" by incubating the binding reaction for 1 hour with 5 pg antibodies against STAT 1 (Transduction Laboratories, Lexington, KY) or 1 pg STAT 3 (Santa Cruz Biotechnology, Santa CNZ, CA) on ice before gel electrophoresis.
Western blot analysis. To quantitate expression of chimeric G-CSFR-mpl proteins, equal amounts of transfected COS-l cell cultures were centrifuged for 9 seconds in a microfuge and then lysed in 25 pL, 50 mmol/L Tris-HC1, pH 7.4, 150 mmom NaCI, 1%
Triton X-100, 0.5 mmoVL Na3V04, 1 mmoVL PMSF, 1 mmol/L EDTA, 10 pg/mL leupeptin, and aprotinin. After 20 minutes on ice, the extract was centrifuged for 30 seconds at 13,000g. The supematant was mixed with 25 pL sodium dodecyl sulfate (SDS) sample buffer, boiled for 5 minutes, and applied onto a 6% SDS polyacrylamide gel. The separated proteins were electroblotted onto ImmobiIon membrane (Millipore, Boston, MA). The membrane was incubated for 6 hours with sheep antihuman G-CSFR (generously provided by Dr D. Tweardy, Pittsburgh Cancer Institute, Pittsburgh, PA). The membrane was then treated with rabbit antigoat Ig followed by '251-labeled goat antirabbit Ig and exposed for 3 days to X-ray film. For analyzing expression of JAKl and JAK2, equal amounts of H-35 and HepG2 cells were lysed as described above and postnuclear supernatant was separated on 6% SDS polyacrylamide gel. The Western blot was probed with either rabbit antihuman JAKl or rabbit antimouse JAK2 (Upstate Biotechnology, Inc. Lake Placid, NY) and the immune complex was visualized by chemiluminescent reaction according to the procedure of the supplier (New England Nuclear, Boston, MA).
RESULTS
Oligonucleotides antisense to c-mpl inhibit IL-3-induced megakaryocyte colony formation from CD34+ progenitors.
In an attempt to understand the role of c-mpl in the regulation of megakaryocytopoiesis, we used the antisense oligonucleotide approach described by Methia et al.' 4 As previously observed, c-mpl antisense oligonucleotides AS-3 and AS-6 (derived from sequence at the initiator methionine and extracellular insert domain, respectively) inhibited the production of megakaryocyte colony formation (Cm-MK) from CD34+ bone marrow stimulated by IL-3 plus aplastic anemia serum (AAS) as a source of TPO (Fig 1) . These results are consistent with the known action of c-mpl as the receptor for TPO. Intriguingly, CFU-MK-derived colony formation in response to IL-3 alone was inhibited by AS-3 but not by AS-6 (Fig 1) . These results suggested that E -3 might act on CFU-MK via three alternative pathways: (1) IL-3 stimulated the production of TPO; (2) TPO was produced by accessory cells in the cell culture, or was introduced by the assay medium, and synergized with IL-3; or (3) IL-3 signaled via a c-mpl-containing receptor complex. To test the first two possibilities, cultures of CD34+ cells were stimulated with IL-3 and the resulting conditioned medium as well as the medium used for treatment were measured for TPO activity by bioassay on BAF/c-mpl cells. TPO expression by CD34' cells was also determined by RT-PCR for TPO mRNA. In neither assay system was TPO production detected (data not shown). We, therefore, assessed whether AS3 has lowered expression of IL-3Ra or IL-3RP by mRNA analysis of the treated cells. However, we were unable to detect any effect of AS-3 on IL-3Ra or IL-3RP mRNA expression in TF-1 cells (data not shown). 
AS-3 S-6 AS-6
Oligonucleotide Added to Culture Because this analysis of receptor expression could not provide any information on functional cooperation of IL-3R subunits with c-mpl, a separate approach was needed to define whether IL-3 could act through a c-mpl-containing receptor complex. Previous studies have used the IL-3-responsive murine cell line BAF-3 for c-mpl receptor reconstitution.'"'." As a consequence, we turned to an alternate receptor reconstitution system involving IL-3R-and cmpl-negative hepatoma cells to test the interaction of c-mpl and subunits of the IL-3R complex.
c-mpl mediates specijic gene regulation in rat hepatoma cells. To determine whether c-mpl exerted a gene regulatory function similar to other members of the hematopoietin receptor gene family, we transfected expression vectors encoding human c-mpl, together with the hematopoietin receptor-responsive CAT reporter gene construct, p(8xHRRE)-CAT, into rat hepatoma H-35 cells. The activity of c-mpl was compared with that of similarly transfected heterodimeric IL-3R and GM-CSFR and to the predicted homodimeric G-CSFR-mpl chimera (Fig 2) . Based on Northern analysis, all transfected receptor plasmids were transcribed and yield low MORELLA ET AL but comparable levels of polyadenylated mRNA of the predicted sizes (data not shown). The CAT activities measured in the transfected cells indicated that c-mpl mediated a TPOspecific increase of the reporter gene expression. However, the untreated cells showed an elevated basal expression that ranged from 7-to 30-fold, depending on the final density of the test cultures. A minor autocrine stimulation appeared to occur in H-35 cells. Indeed, when adding concentrated conditioned medium of untransfected and untreated H-35 cells to c-mpl-transfected HepG2 cells (which do not show signs of autocrine stimulation; see below) a c-mpl-dependent CAT gene activity above the control levels was observed. No autocrine action nor TPO response was detectable when either IL-3R, GM-CSFR, or G-CSFR-mpl were transfected in H-35 cells. The assay data also illustrate that the COS-cell-derived TPO preparations did not contain detectable stimulatory activities other than TPO. The maximal level of CAT gene regulation achieved with TPO-activated c-mpl was comparable to that observed with the endogenous IL-6R or with the other transfected hematopoietin receptors.
The specificity of the c-mpl signal for gene-regulatory elements was assessed by cotransfecting c-mpl and CAT reporter gene constructs containing various characteristic response elements into H-35 cells (Fig 3) . Despite a low autocrine response, a TPO-mediated activation of the CytRE of the rat a,-acid glycoprotein gene was obtained. No regulatory effect was recorded with the high-affinity sis-inducible element of the c-fos gene nor with the IL-6RE of rat hemopexin gene. The responsiveness of each reporter gene used was defined in the same cell cultures by the stimulation via the appropriate endogenous cytokine receptor.
The data indicated that c-mpl generated gene-regulating signals in H-35 cells that were, in part, similar to those generated from the endogenous receptors for IL-6-type cytokines. The specificity of gene regulation by c-mpl coincided with that of G-CSFR-mpl,'3 IL-3R, and GM-CSFR (data not shown). Because c-mpl, IL-3R, and GM-CSFR activated both HRRE and CytRE but not the IL-6RE, we concluded that these receptors are devoid of a box 3-restricted signal capability. '3 c-mpl shows cell-line spec&-dlfSeerence.7 in signuling reaction. H-35 cells, among different hepatic tissue culture cells, have proven to be best suited for defining the signal specificity of hematopoietin receptor^.^^^^'^'^ However, because we expressed human c-mpl in rat cells, we repeated the analysis with human HepG2 cells to assess whether a species-restricted signal pathway existed for c-mpl. In the transiently transfected HepG2 culture cells, as in H-35 cell cultures, quantitation of receptor protein was technically not feasible.
However, Northern blot analysis indicated that all receptor constructs were expressed and that an approximately 2-to 10-fold higher level of each receptor mRNA was achieved in HepG2 cells than in H-35 cells. The highest expression among the receptor constructs was consistently observed with G-CSFR-mpl (data not shown). In separate experiments, we had verified that the amount of each receptor expression vectors used for transfection of two hepatoma cell lines was greater than what was needed for gaining maximal cell regulation (see also Baumann et all')).
The CAT reporter gene responses (Fig 4) For 6R and transfected IL9R (Fig 5A) . The IL-3R produced a similar dose response to IL-3 in both cell types with halfmaximal activation of the reporter gene at 0.03 to 0.1 ng/ mL. TPO dose response in c-mpl-transfected H-35 cells yielded a maximal stimulation with 1/100 diluted COS-cellderived TPO preparation (5,000 U/mL) with a half-maximal stimulation at 1 X dilution (-5 U/mL). By contrast, in c-mpl-transfected HepG2 cells, no true maximal stimulation of the reporter construct was achieved under the conditions used in Fig 5A. When compared with the H-35 cell response, c-mpl in HepG2 cells was approximately 100 times less sensitive to TPO.
Two potential mechanisms could explain the cell-type difference in c-mpl action: ( l ) an additional receptor subunit is needed for optimal c-mpl action, and this subunit is more prevalent in H-35 cells than in HepG2 cells; and/or (2) the c-mpl-mediated cytoplasmic signaling reaction requires specific mediators and HepG2 cells, but not H-35 cells, are deficient in those. Although additional subunits have been described for many other receptors of this family, the latter explanation appeared more likely to apply because transfected G-CSFR-mpl showed a similarly low sensitivity to ligand as c-mpl in HepG2 cells (Fig 5A) . We assume that the G-CSFR does not require additional subunits for optimal dose responsiveness, although this remains to be proven. Because we could not rule out the participation of an additional receptor subunit in c-mpl function, we tested combinations of c-mpl with other cloned members of hematopoietin receptors for enhanced TPO response in HepG2 cells. We were unable to achieve any functional cooperativity with any subunits known to participate in heteroligomerization. ie, IL-2RP or -7, IL-3Ra or -0. GM-CSFRa, LIFR, IL-4R, IL-7R, and gp130 (Fig 5B, and data not shown) and conclude that none of the tested receptor subunits are part of the functional TPO receptor. We hypothesize that c-mpl acts as a homodimer or homo-oligomer and that c-mpl and IL-3R, although having a comparable specificity of gene regulation, do not use identical signal transduction pathways accounting for the cell-line-specific difference.
c-mpl mediates STAT protein activation. Signal initiation by hematopoietin receptors is accompanied by the activation of STAT proteins that are generally recognized by their binding to the high-affinity SIE sequence, forming large molecular size complexes migrating with mobilities such as observed for SIF-A, -B, and -C on polyacrylamide gel.39 STAT proteins have been suggested to partake in stimulating transcription of specific genes, yet a causal role in regulating genes in cells remains to be proven in most instances." Although c-mpl was unable to stimulate gene expression via SIE or IL-6RE (Fig 3) , a process that has been suggested to involve SIF-A complex containing a dimer of STAT3 (or APRF)? we attempted to determine whether the action of c-mpl involved an activation of any SIFs. Therefore, we transfected c-mpl into L and COS-l cells that yielded a higher transfection efficiency and receptor expression levels than did hepatoma cells and thus enabled a characterization of the receptor-initiated signaling event.*' Moreover, in L cells, the function of the transfected receptor could also be monitored by the stimulation of p(8xHRRE)-CAT reporter construct as in hepatic cells, albeit at much lower magnitude (Fig 6) . Both c-mpl and G-CSFR-mpl reconstituted not only a HRRE-CAT gene stimulation (Fig 6A) , but also an induction of SIFs (Fig 6B) .
The SIF complex that was activated by c-mpl, comigrated with the IL-6-induced SIF-A and each of these complexes was recognized by anti-STAT3 but not anti-STAT1 antibodies, as evidenced by supershift assay (Fig 6E and data not  shown) . This finding suggests that the c-mpl was able to activate STAT3 containing DNA-binding complex similar to what has been defined for IL-6R.
The relative activation of SIFs by G-CSFR-mpl was somewhat higher than by c-mpl. This quantitative difference was even more prominent in COS-l cells (Fig 6C) , which have an approximately IO-fold higher expression level of transfected plasmids than L cells. Of note is that, although c-mpl induced in L cells primarily the SIF-A (Fig 6B) , in COS-l cells, c-mpl, like other transfected hematopoietin receptors, such as IL-JR, stimulated an SIF complex that migrated with SIF-C (Fig 6C) , the SIF form that predominates in IFN-y-treated cells and probably is composed of STAT1 homodimer?"' By antibody reaction, we verified that most of the c-mpl-induced SIF in COS-l cells appeared to contain STAT1 but not STAT3 (Fig 6E and data not shown) .
Because we have determined the SIF-inducing action of c-mpl in transfected cells of nonhematopoietic lineages, we corroborated this receptor activity in HEL and Mo7e cells that normally express c-mpl (Fig 6D) . As observed for L cells, TPO treatment of the two leukemic cell lines produced with:
an increase of the SIF form comigrating with SIF-A and Taken together, these results indicate that the signaling immunoreacting with anti-STAT3 (Fig 6E) . Unlike hepafunctions of c-mpl or the chimeric G-CSFR-mpl construct toma cells25a and fibroblasts (Fig 6B and C) , HEL cells disinclude STAT protein activation and stimulation of gene played a high basal activity for SIF activity comigrating with transcription via HRRE and CytRE. Yet to be determined is SIF-B and -C.
whether these two processes are causally connected. 
C-MPL AND IL-3R SIGNAL TRANSDUCTION
Zdentijcation offunctionally relevant subregion in the cytoplasmic domain of c-mpl. To define the cytoplasmic domain regions that are required for signaling function, a series of deletions were introduced into G-CSFR-mpl constructs (Fig 7, top) . The deletions were patterned after the series used by BCnit et a l l z for identification of the regions controlling pathogenicity of v-mpl. The mutations selectively removed either box 1 motif (Al), box 2 motif (A2), or the carboxy terminal part containing the regions with tyrosine residues in a sequence context potentially involved in signaling functions (A3 and A4). The reasons for using G-CSFRmpl rather than c-mpl were (1) this receptor form was highly active in hepatic and fibroblastic cells; (2) the gene-regulatory action could be determined in H-35 cells without autocrine contribution; and (3) the receptor expression could be assessed by using the available anti-G-CSFR antibodies.
The vectors for the various receptor mutants directed a similar level of receptor protein expression in transiently transfected COS-l cells as determined by Western blot analysis (Fig 7, top) . The same expression vectors, together with HRRE-CAT gene introduced into H-35 cells, indicated that A3 mutant was equally active as the full-length c-mpl. No gene-stimulatory activity was detectable for A1 and the truncated forms, S S and SC. Approximately 10% of the activity of the full-length c-mpl form was measured for A2 and A4. SIF activation profile correlated with gene regulation with the exception of mutant A2, which had low gene regulatory activity but no detectable action on STAT proteins. Transfection of pairwise combinations of A1 and A2, A1 and A4, or A2 and A4 failed to produce a complementation of the signaling function to the wild-type level (data not shown). In summary, the data suggest that (1) signaling of c-mpl is critically dependent on the presence of the membraneproximal segment containing the box 1 motif; (2) maximal action requires the region of the box 2 motif and the carboxy terminal 22 amino acid segment; and (3) HRRE regulation is not strictly correlated with the ability of c-mpl to activate
SF.
JAK2 participates in c-mpl signal communication. It has been shown for several hematopoietin receptors, such as GHR, EPOR, and IL-3RP, that the box 1 motif was critical 565 for activation of JAK2."7-5' The results of Fig 7 suggest that JAKZ may also play a role in signaling by c-mpl via interaction with the box 1 motif. Furthermore, we hypothesized that the cell-line-specific difference in c-mpl action described in Fig 5A may be caused by different levels of JAK2 expression or by differences in the availability of JAK2 for action of the transfected receptors. One indication for potential JAK2 deficiency in HepGZ cells was the inability of HepG2 cells to stimulate HRRE-CAT gene expression with transfected receptor constructs containing just box 1 motif, such as G-CSFR-mplA2 (Fig 8B, below) .
We determined the level of immunoreactive JAKl and JAK2 in HepG2 and H-35 cells by Western blot analysis and observed, under the condition used, an equal signal for JAK1. However, a several-fold higher signal for JAK2 was observed in H-35 cells than in HepG2 cells (Fig 8A) . Because this analysis did not provide conclusive evidence about biologically relevant levels of JAK2 in these cell lines, we assessed the potential role of JAK2 in c-mpl signaling by two alternative approaches, either by enhancing c-mpl response through overexpression of active JAK2 (Fig 8A) or inhibition of c-mpl action by overexpression of the dominantnegative JAK2AVIII. 35 HepGZ cells appeared to be the optimal system for applying these approaches because the cmpl response in this cell line was expected to allow for the enhancement as well as inhibition.
Transfection of increasing amounts of expression vector for JAK2 showed that, at concentrations less than 1 pg/mL, expression vector had little enhancing effect on basal activity of cotransfected p(8XHRRE)CAT construct. However, at concentrations greater than 1 pg/mL, a significant increase in basal expression occurred (data not shown). Transfection of the combination of either c-mpl or G-CSFR-mpl with JAK2 resulted in a several-fold elevation of basal expression of the CAT construct, even with a JAK2 plasmid concentration as low as 0.05 pg/mL. We established empirically the concentrations of JAK2 and receptor expression vectors (as applied in Fig 8B) that yielded an optimal manifestation of the JAK2 action on c-mpl signaling. JAK2 enhanced the regulation of the HRRE-CAT construct by c-mpl and G-CSFR-mpl to a level equal or exceeding that achieved by Fig 8B, top two panels) . The JAK2 effect was dependent on the box 1 motif in the cytoplasmic domain of cmpl because the box l-deficient mutant, G-CSFR-mplAl, remained inactive (data not shown), whereas the box 2-deficient mutant, G-CSFR-mplA2, showed a prominent JAK2 response (Fig 8B, bottom panel) . The same experimental system also indicated that the regulation via the endogenous IL-6R was relatively unaffected by overexpressed JAK2. Similarly ineffective was JAK2 in modulating the maximal regulation by transfected IL-3R (data not shown).
IL-6 (
To assess in HepG2 cells the contribution of resident JAK2 to the c-mpl signaling reaction, we transfected receptors together with relatively high amounts of dominant-negative JAK2AVIII into the cells (Fig 8C) . The presence of inactive JAK2 caused a minor reduction in the basal activity of the reporter gene and attenuated the activation by c-mpl by threefold to sevenfold. In contrast, the action of the transfected IL-3R and the endogenous IL-6R was insignificantly affected.
The results in Fig 8 support a model that c-mpl requires JAK2 for producing a signal leading to gene regulation in hepatic cells. IL-3R is equally effective in controlling the same gene element as c-mpl, but uses an alternative mechanism that is not critically dependent on JAK2.
DISCUSSION
We have applied antisense oligonucleotides to c-mpl to assess the role of TPO in megakaryocytopoiesis. The results have supported the proposed function of c-mpl. However, the unexpected observation that AS-3 reduced the TPO and the IL-3 response of the cells in a similar fashion sparked a study in which we attempted to define signaling of c-mpl and its relationship to IL3R action.
At present, we are unable to provide a molecular explanation for the differential effects of AS-3 and AS-6 (Fig 1) . The antisense oligonucleotide experiments are not trivially explained by toxic effects of the AS-3 preparation because the experiments were reproducible with independently synthesized lots of the oligonucleotide (data not shown). The AS-3 sequence corresponds to the initiator methionine region of c-mpl, whereas the AS-6 sequence corresponds to the unusual hydrophilic insert domain of the first hematopoietin receptor repeat.' A search of the GenBank by the BLAST algorithm did not yield any recorded sequence (besides human c-mpl) that contains a relevant match to the 18 nucleotides of AS-3 and AS-6. The hydrophilic insert is conserved between mouse and human c-mpl but is not found in any other member of the hematopoietin receptor family. c-Mpl is most like the IL-3R in overall structure, comprising two repeats of the hematopoietin receptor domain." Because the IL-3R subunits have no insert domain, a possible explanation for the inhibition of IL-3-induced CFU-MK-derived colony formation by AS-3 and not AS-6 is the existence of a variant or homolog of c-mpl that lacks the insert domain and signals in response to IL-3. We attempted to identify such a variant by RT-PCR of CD34+ bone marrow cells using oligonucleotides spanning the insert domain. We did not find evidence for any alternative splicing in this region leading to the formation of a membrane-bound variant of cmpl that lacks the hydrophilic insert. Instead, a spliced variant was detected that corresponded to the deletion of the majority of the insert domain (nt 499-691) and that terminated at nt 701 (Ho, Gorvad, and Gearing, unpublished data). Because this variant truncated before the first Trp-Ser-Xaa- Trp-Ser motif, we assume that it does not represent a functional form of the soluble c-mpl, although this still remains to be tested.
Because we could not rule out the possibility that c-mpl and IL-3R subunits cooperate in CD34+ cells, we decided to characterize the signaling function of each of the participating receptor components in the heterologous systems of hepatoma cells and fibroblasts. The major advantages of choosing gene regulating signal as reporter for the receptor functions are that the receptor action can efficiently be quantitated in transiently transfected cells, categorized based on the specificity of the activated genetic targets, compared with the action of other related hematopoietin receptors, and the complexity of the suspected signaling molecules can be defined experimentally by complementation.
The reconstitution of c-mpl and IL-3R response in hepatoma cells (Figs 2 and 4) shows that the receptors are capable of recruiting the resident signal-transducing mechanisms. The magnitude and dose response of the activation of the HRRE-CAT constructs (Figs 5 and 8) illustrate that this recognition is equivalent to that mediated by endogenous IL-6-type cytokine receptors. This similarity of the cell response mediated by c-mpl and IL-3R suggests that the two receptors may use the same signaling mechanisms. However, comparison of gene element specificity (Figs 2 and 3 ) also indicated that neither c-mpl nor IL-3R execute the entire signaling program available in the hepatoma cells. The most distinguishing feature is the inability of c-mpl and IL-3R to activate the IL-6RE-containing reporter gene, a process that depends on a box 3 motif in the cytoplasmic domain of the signal transducing receptor subunit.** Therefore, we conclude that neither c-mpl nor IL-3R cytoplasmic domain structures include a motif that is functionally equivalent to the box 3 motif of gp130.
The prominence and sensitivity of the gene regulation mediated by the transfected receptor subunits were used as evidence that c-mpl acts independently of IL-3Ra or -p subunits. Moreover, because we could not ascribe a modulating activity to several other cloned hematopoietin receptor subunits, we propose that c-mpl functions as a homodimer analogous to G-CSFR, EPOR, PRLR, and GHR. 4 The observation that G-CSFR-mpl elicits a c-mpl-like response ( Fig  5 ) supports the model that homodimerized cytoplasmic domain of c-mpl has signaling activity. Although a c-mpl homodimer is strongly suggested, an alternative hetero-oligomeric complex that contains resident but undefined receptor subunits cannot formally be ruled out. Indeed, c-mpl seems to have the capability of signaling when present in an artificial heteromeric complex, as suggested by the report of Skoda et al. ' In this system, the chimeric IL-4R-c-mpl receptor generates a proliferative response in transfected cells, probably via association with endogenous IL-2RyS2," or an alternative mechanism independent of I L -~R Y . '~ One caveat of testing hematopoietin receptors in a heterologous system is that the host cell may not contain cell-typerestricted signaling molecules that are needed for c-mpl action such as JAKs, STATs, src-related kinase, and their respective substrates. Moreover, the difference in the level of expression of limiting signal molecules that might be ubiquitous to all cells seems also to affect the regulatory phenotype of the receptor-transfected cell, as implied by JAK2 supplemental experiment in Fig 8. At present, we do not know of any signaling molecules that are used by c-mpl in homologous cell systems and that are not found in hepatic cells. If the heterologous systems should prove to be deficient in a component needed for c-mpl action in megakaryocytic cell types, then the cells studied here will be of value for testing the function of the component by complementation.
A part of the signaling reaction of c-mpl involves the activation of SIF-A in hematopoietic cells (Fig 6D) . The DNA binding activities of the STAT protein induced by cmpl were identified with SIE as substrate, a sequence known to be recognized by several STAT proteins (STAT-l, -3, -4, and -5).15,1h We had also applied other DNA sequences representing the IFN-y activation site (GAS) of the Fc-receptor-y gene (bound by STAT-l, -3. -6),'5.'h.55 the acute-phase response element (APRE) of the a,-macroglobulin gene (bound by STAT-l and -3),36,37 and the PRL-response element of the /?-casein gene (bound by STAT5).56 However, none of these elements indicated any STAT complexes in addition to those already defined by SIE (data not presented). The SIF-A activation process seen in hematopoietin cells could be faithfully reproduced in c-mpl-transfected L cells (Fig 6B) . The SIF-A complex in both cell types includes the STAT3 protein (Fig 6E) , a known target of the EGFR and IL-6R pathway." We failed to observe a c-mpl-mediated response via S E or IL-6RE (Fig 3) despite the capability of c-mpl to activate STAT proteins, suggesting that either the SIF activity is not sufficient for regulation through these elements or the c-mpl effect on STAT proteins is below the threshold for being effective.
Although c-mpl transfected into COS-1 cells is abundantly expressed and capable of activating SIF ( Figs 6C and 7) , the contributing component to the SIF complex is STATl , not STAT3. This switch in STAT isoform is not caused by the lack of STAT3 in COS-l cells as seen by the abundance of SIF-A after IL-6 treatment. A possible explanation might be seen in the massive overexpression of receptor proteins in the individually transfected cells, and that in those cells STAT3 is limiting and STATl acts as the default target."" Ongoing complementation experiments using cotransfection of expression vectors for STATl or STAT3 and c-mpl show that c-mpl can similarly activate STAT3 and STATl (Lai, Morella, Ripperger, Fey, and Baumann, unpublished data).
Aside from cell-type-specific variations in STAT protein usage, the reconstitution experiments showed convincingly that the signaling functions of c-mpl to STAT proteins and to gene elements depend on specific cytoplasmic domain regions (Fig 7) . It is not surprising that the box l motif plays such a critical role, because equally critical requirements have been ascribed to the box 1 motif of other hematopoietin receptors inducing IL-3R/?, gp130, G-CSFR, IL-3R0, EPOR, and GHR for controlling proliferation and activation of immediate growth-response genes! As described previously,'2 the deletion of box 1 from v-mpl ( A l ) abolished pathogenicity that coincides with the loss of gene regulation in our system, suggesting overlap in control mechanisms that is related to proliferation and gene expression in different assay systems. This apparent concordance in control of separate cell responses by c-mpl is not perfect, as noted by For personal use only. on October 31, 2017. by guest www.bloodjournal.org From the analysis of deletion mutants (Fig 7) . Whereas A3 and A4 mutants of env-mpl supported similar pathogenicity, the same mutant pair showed substantially different abilities to activate S F and HRRE in our assays (Fig 7) . We conclude from these results that the carboxy terminal sequence of cmpl is needed for gaining maximal gene regulation and SIF induction but is not essential for proliferation control.
A similar organization of distinct control elements in the cytoplasmic domain has been observed for, other hematopoietin receptors such as IL-3Rp,'8.57 EPOR:0,47 G-CSFR,19,24 IL-2Rp,20s58 and gp130. 22, 59 What still remains to be defined is the identity of the signal transducing molecules for each of the activated cell processes. In particular, it will be crucial to define whether the STAT protein pathway is restricted to the control of gene transcription and the activation of ras-dependent pathways for control of proliferaThe complexity of the signal transduction mechanisms activated by c-mpl and IL-3R was apparently caused by the differential sensitivity of the receptors to intracellular JAK2 concentration (Fig 8) . The data indicated a strong dependence of the c-mpl action on JAK2. Although JAK2 has been found associated with the IL-3RP subunit, as well as with gp130,51,57,61.62 the signaling reactions of both IL-3R or IL-6R are substantially less dependent on JAK2 than on c-mpl. This finding suggests that other JAK2-independent pathways participate in the signaling through these receptors. However, the end effects of these pathways on the activation of gene expression via HRRE or CytRE appear to be comparable. Delineation of the biochemical basis of these pathways and determination of the compatibility of the signaling mechanisms among hepatic cells, fibroblasts, and hematopoietic cells will be required before postreceptor effects stimulated by TPO can be fully understood. tion4,15,16.60 or whether these pathways overlap in the control
